High dose rate endovascular brachytherapy in aorto-iliac lesion for the prevention of restenosis.
This study examined the applicability of endovascular brachytherapy to larger del arteries such as the abdominal aorta and iliac artery. Endovascular brachytherapy using an Ir-192 HDR source was administered 11 times to nine patients who had undergone percutaneous transluminal angioplasty (PTA) between 1995 and 1999. The follow-up lasted 13 to 55 months after treatment (median, 24 months). Eight of the 11 lesions have been controlled so far. Although one case developed thrombus inside the stent five months later, recanalization was achieved by means of retreatment. One patient who underwent low-dose irradiation (6 Gy) without stent implantation showed restenosis five months after treatment. We used a centering catheter that did not block the blood stream for exact centering of the radiation source in larger vessels such as the abdominal aorta. Although endovascular brachytherapy is a promising and safe procedure, careful follow-up is needed to detect untoward reactions such as thrombosis.
Yamazaki
Hideya
H
Department of Radiology, Toyonaka Municipal Hospital, Japan.
Tomoda
Kaname
K
Shiomi
Hiroya
H
Maeda
Munehiro
M
Kawata
Shuji
S
Okada
Atsuya
A
Murakami
Takamichi
T
Nakamura
Hironobu
H
Tanaka
Eiichi
E
Inoue
Takehiro
T
Inoue
Toshihiko
T
D000368:Aged; D000369:Aged, 80 and over; D001018:Aortic Diseases / Q000532:radiotherapy*; D001157:Arterial Occlusive Diseases / Q000532:radiotherapy*; D001918:Brachytherapy / Q000379:methods*; D003251:Constriction, Pathologic / Q000517:prevention & control; D006801:Humans; D006965:Hyperplasia / Q000517:prevention & control; D007083:Iliac Artery; D007496:Iridium Radioisotopes / Q000627:therapeutic use*; D008297:Male; D017539:Tunica Intima
D007496:Iridium Radioisotopes